‘Peak Euphoria’ Seen as Small Companies Jump on the AI Bandwagon

A tiny pharmaceutical company in danger of being delisted from the Nasdaq stock exchange went from celebrating new patents for cancer treatments to re-branding as an AI company in the period of two months. The move rescued its share price in the process, albeit briefly.

Shares of Qualigen Therapeutics, now known as AIxCrypto Holdings LLC and trading under the ticker AIXC, more than doubled in late September after the change.